NO20020718L - Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS - Google Patents

Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS

Info

Publication number
NO20020718L
NO20020718L NO20020718A NO20020718A NO20020718L NO 20020718 L NO20020718 L NO 20020718L NO 20020718 A NO20020718 A NO 20020718A NO 20020718 A NO20020718 A NO 20020718A NO 20020718 L NO20020718 L NO 20020718L
Authority
NO
Norway
Prior art keywords
ras
methods
protein kinase
compositions useful
modulating angiogenesis
Prior art date
Application number
NO20020718A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020718D0 (no
Inventor
David A Cheresh
Brian Eliceiri
John Hood
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20020718D0 publication Critical patent/NO20020718D0/no
Publication of NO20020718L publication Critical patent/NO20020718L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20020718A 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS NO20020718L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14892499P 1999-08-13 1999-08-13
US21595100P 2000-07-05 2000-07-05
PCT/US2000/021842 WO2001012210A1 (fr) 1999-08-13 2000-08-11 Techniques et compositions convenant pour la modulation de l'angiogenese a base de proteinekinase raf et de kinase ras

Publications (2)

Publication Number Publication Date
NO20020718D0 NO20020718D0 (no) 2002-02-12
NO20020718L true NO20020718L (no) 2002-04-10

Family

ID=26846311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020718A NO20020718L (no) 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS

Country Status (17)

Country Link
US (1) US20060040853A1 (fr)
EP (1) EP1210099A4 (fr)
JP (1) JP2003507337A (fr)
KR (2) KR100805098B1 (fr)
CN (1) CN1208087C (fr)
AU (1) AU781877B2 (fr)
BR (1) BR0013228A (fr)
CA (1) CA2380966A1 (fr)
CZ (1) CZ2002449A3 (fr)
HK (1) HK1050856A1 (fr)
HU (1) HUP0300923A3 (fr)
MX (1) MXPA02001553A (fr)
NO (1) NO20020718L (fr)
PL (1) PL364928A1 (fr)
RU (1) RU2257911C2 (fr)
SK (1) SK2142002A3 (fr)
WO (1) WO2001012210A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002223571A1 (en) * 2000-09-29 2002-04-08 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh Pharmaceutical compositions comprising polynucleotides encoding a raf protein
KR101737753B1 (ko) * 2007-03-12 2017-05-18 와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 페닐 아미노 피리미딘 화합물 및 이의 용도
JP2011510011A (ja) * 2008-01-14 2011-03-31 ジェネンテック， インコーポレイテッド Ｅｇｆｌ８アンタゴニストを使用する血管新生阻害方法
EP2329854A3 (fr) * 2009-12-04 2014-02-19 Biotronik VI Patent AG Revêtement d'implant doté d'acides nucléiques
CN102766601B (zh) * 2011-11-17 2015-12-16 中山大学肿瘤防治中心 含有可诱导型癌基因的细胞系及其建立方法、应用
WO2015185977A1 (fr) * 2014-06-03 2015-12-10 Arturo Solis Herrera Modèles animaux de l'angiogenèse cornéenne et maladies ectasiques de la cornée, procédés de production, et ses procédés d'utilisation
RU2728870C2 (ru) * 2017-10-12 2020-07-31 Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения российской федерации (ФГБУ "РНЦРР" Минздрава России) Полипептиды для лечения онкологических заболеваний
US20230218710A1 (en) * 2020-04-15 2023-07-13 Cohbar, Inc. Method of treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618670A (en) * 1988-08-26 1997-04-08 The United States Of America As Represented By The Department Of Health & Human Services Detection method for c-raf-1 genes
US5156841A (en) * 1988-08-26 1992-10-20 United States Of America Anti-tumor vaccine
US5656612A (en) * 1994-05-31 1997-08-12 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5597719A (en) 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
WO1998021585A1 (fr) * 1996-11-15 1998-05-22 Cornell Research Foundation, Inc. Dosage d'interaction de ras activee
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
EP1210099A1 (fr) 2002-06-05
KR100759241B1 (ko) 2007-09-18
CN1378457A (zh) 2002-11-06
KR20070067210A (ko) 2007-06-27
WO2001012210A1 (fr) 2001-02-22
AU6763300A (en) 2001-03-13
EP1210099A4 (fr) 2006-01-18
KR20020032553A (ko) 2002-05-03
CZ2002449A3 (cs) 2002-08-14
MXPA02001553A (es) 2003-05-23
NO20020718D0 (no) 2002-02-12
WO2001012210A9 (fr) 2002-09-12
CN1208087C (zh) 2005-06-29
AU781877B2 (en) 2005-06-16
JP2003507337A (ja) 2003-02-25
HUP0300923A3 (en) 2005-12-28
KR100805098B1 (ko) 2008-02-20
HUP0300923A2 (hu) 2003-07-28
PL364928A1 (en) 2004-12-27
CA2380966A1 (fr) 2001-02-22
SK2142002A3 (en) 2002-07-02
US20060040853A1 (en) 2006-02-23
BR0013228A (pt) 2003-06-17
RU2257911C2 (ru) 2005-08-10
HK1050856A1 (en) 2003-07-11

Similar Documents

Publication Publication Date Title
NO20031500D0 (no) Brodekkepaneler, fremgangsmåte for fremstilling av samme og broer omfattende samme
NO992336D0 (no) Raf-kinase-inhibitorer
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
AU2002238042A1 (en) Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
NO995660L (no) FremgangsmÕte ved kommunikasjon og anordning for samme
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO20012774L (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
NO20024762L (no) FremgangsmÕte for modellering av feiling og frakturering i jorden
IS6724A (is) Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra
NO20021736D0 (no) Nytt preparat og fremgangsmåte for stabilisering av det
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20013803D0 (no) Polymert adsorpsjonsmiddel og fremgangsmåte til fremstilling av samme
NO20021989L (no) Törkingsanlegg og metode for törking av ved
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK1001684T3 (da) Afvandede kartoffelstykker og fremgangsmåde til deres fremstilling
NO20006296D0 (no) Fremgangsmåte til fremstilling av filtpapp og filtpapp
NO20020718L (no) Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS
NO993437D0 (no) Koplingsanordning og fremgangsmåte til bruk av koplingsanordningen
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
NO20012050L (no) Fremgangsmate og oppstilling for maling av tre
NO20004349D0 (no) Metoder og anordninger for modulering av immunresponsen
DE60028202D1 (de) Behälter zum einschluss von kernbrennelementen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application